82 FR 51873 - Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2018
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 82, Issue 215 (November 8, 2017)
Drug Enforcement Administration
Federal Register Volume 82, Issue 215 (November 8, 2017)
| Page Range | 51873-51877 | |
| FR Document | 2017-24306 |
[Federal Register Volume 82, Number 215 (Wednesday, November 8, 2017)] [Notices] [Pages 51873-51877] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-24306] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-471F] Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2018 AGENCY: Drug Enforcement Administration, Department of Justice. ACTION: Final order. ----------------------------------------------------------------------- SUMMARY: This final order establishes the initial 2018 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. APPLICABLE DATE: Applicable November 8, 2017. FOR FURTHER INFORMATION CONTACT: Michael J. Lewis, Diversion Control Division, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, VA 22152, Telephone: (202) 598-6812. SUPPLEMENTARY INFORMATION: Legal Authority Section 306 of the Controlled Substances Act (CSA) (21 U.S.C. 826) requires the Attorney General to establish aggregate production quotas for each basic class of controlled substance listed in schedules I and II and for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. The Attorney General has delegated this function to the Administrator of the DEA pursuant to 28 CFR 0.100. Background The 2018 aggregate production quotas and assessment of annual needs represent those quantities of schedule I and II controlled substances and the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine that may be manufactured in the United States in 2018 to provide for the estimated medical, scientific, research, industrial needs of the United States, lawful export requirements, and the establishment and maintenance of reserve stocks. These quotas include imports of ephedrine, pseudoephedrine, and phenylpropanolamine, but do not include imports of controlled substances for use in industrial processes. On August 7, 2017, a notice titled ``Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2018'' was published in the Federal Register. 82 FR 36830. This notice proposed the 2018 aggregate production quotas for each basic class of controlled substance listed in schedules I and II and the 2018 assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. All interested persons were invited to comment on or object to the proposed aggregate production quotas and the proposed assessment of annual needs on or before September 6, 2017. Comments Received Within the public comment period, the DEA received seventeen comments from three DEA-registered manufacturers regarding sixteen different schedule I and II controlled substances and one comment from a DEA-registered manufacturer regarding the proposed assessment of annual needs for the list I chemical phenylpropanolamine (for conversion). Commenters stated the proposed aggregate production quotas for 4-anilino-n-phenethyl-4-piperadine (ANPP), amphetamine (for conversion), codeine (for sale), diphenoxylate, fentanyl, gamma hydroxybutyric acid, hydrocodone (for sale), lisdexamfetamine, methadone, methadone-intermediate, methylphenidate, morphine (for conversion), morphine (for sale), oxycodone (for sale), oxymorphone (for sale), sufentanil, as well as the proposed assessment of annual needs for phenylpropanolamine (for conversion), were insufficient to provide for the estimated medical, scientific, research, and industrial needs of the United States, export requirements, and the establishment and maintenance of reserve stocks. These comments were considered in setting the final 2018 Aggregate Production Quotas as discussed below. In addition to these seventeen comments, the DEA received one comment from a DEA-registered manufacturer seeking clarification on whether DEA considers manufacturing at outsourcing facilities when determining the Aggregate Production Quotas. The DEA notes that it is the responsibility of all DEA-registered dosage form manufacturers to submit quota applications by April 1, in order for their individual business practices to be considered when the DEA proposes the Aggregate Production Quota for the following year. 21 CFR 1303.12(b). These quota applications and comments with discrete data regarding the quantities of the basic classes of schedule I or II controlled substances received during the comment period for the proposed Aggregate Production Quotas are taken into consideration before establishing the values presented in this Final Order. This DEA-registered manufacturer provided no quantitative data supporting the position that the proposed quota for 2018 will adversely impact outsourcing facilities for DEA to consider. The DEA also received one hundred five comments that expressed concern that DEA's proposed reduction of opioids by twenty percent would adversely impact the availability of pain relieving prescription drugs for people with chronic pain. These comments were general in nature, and raised issues of specific medical illnesses and medical treatment, and therefore are outside of the scope of this Final Order for 2018. As a result, these one hundred and six comments did not provide new discrete data for consideration, and do not impact the original analysis involved in establishing the 2018 aggregate production quotas. Determination of 2018 Aggregate Production Quotas and Assessment of Annual Needs In determining the 2018 aggregate production quotas and assessment of annual needs, the DEA has taken into consideration the above comments along with the factors set forth in 21 CFR 1303.11 and 21 CFR 1315.11, in accordance with 21 U.S.C. 826(a), and other relevant factors, including the 2017 manufacturing quotas, current 2017 sales and inventories, anticipated 2018 export requirements, industrial use, additional applications for 2018 quotas, as well as information on research and product development requirements. Based on all of the above, the Administrator is adjusting the 2018 aggregate production quotas for 2-(4-bromo-2,5-dimethoxyphenyl)-n-(2-methoxybenzyl) ethanamine, 3,4,5-trimethoxy amphetamine, 4-bromo-2,5-dimethoxy- amphetamine, acryl fentanyl, alfentanil, amobarbital, methylphenidate, and nabilone, are warranted. Adjustment to the proposed assessment of annual needs for [[Page 51874]] pseudoephedrine (for sale) was also determined to be warranted. This final order reflects those adjustments. Regarding 4-anilino-n-phenethyl-4-piperadine (ANPP), amphetamine (for conversion), codeine (for sale), diphenoxylate, fentanyl, gamma hydroxybutyric acid, hydrocodone (for sale), lisdexamfetamine, methadone, methadone-intermediate, morphine (for conversion), morphine (for sale), oxycodone (for sale), oxymorphone (for sale), sufentanil, and phenylpropanolamine (for conversion), the DEA has determined the proposed aggregate production quotas and assessment of annual needs are sufficient to provide for the 2018 estimated medical, scientific, research, industrial needs of the United States, export requirements, and the establishment and maintenance of reserve stocks. This final order establishes these aggregate production quotas and assessment of annual needs at the same amounts as proposed. In accordance with 21 U.S.C. 826, 21 CFR 1303.11, and 21 CFR 1315.11, the Administrator hereby establishes the 2018 aggregate production quotas for the following schedule I and II controlled substances and the 2018 assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine, expressed in grams of anhydrous acid or base, as follows: ------------------------------------------------------------------------ 2018 Basic class Established quotas (g) ------------------------------------------------------------------------ Temporarily Scheduled Substances ------------------------------------------------------------------------ Acryl fentanyl.......................................... 25 ------------------------------------------------------------------------ Schedule I ------------------------------------------------------------------------ 1-(1-Phenylcyclohexyl)pyrrolidine....................... 10 1-(5-Fluoropentyl)-3-(1-naphthoyl)indole (AM2201)....... 30 1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole (AM694)...... 30 1-[1-(2-Thienyl)cyclohexyl]piperidine................... 15 1-Benzylpiperazine...................................... 25 1-Methyl-4-phenyl-4-propionoxypiperidine................ 2 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E)........ 30 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D)....... 30 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N)....... 30 2-(2,5-Dimethoxy-4-n-propylphenyl)ethanamine (2C-P)..... 30 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H)................ 30 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2- 30 methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36).............................................. 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C)....... 30 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2- 25 methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82).............................................. 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I)......... 30 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2- 30 methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5)............................................... 2,5-Dimethoxy-4-ethylamphetamine (DOET)................. 25 2,5-Dimethoxy-4-n-propylthiophenethylamine.............. 25 2,5-Dimethoxyamphetamine................................ 25 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) 30 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C- 30 T-4)................................................... 3,4,5-Trimethoxyamphetamine............................. 30 3,4-Methylenedioxyamphetamine (MDA)..................... 55 3,4-Methylenedioxymethamphetamine (MDMA)................ 50 3,4-Methylenedioxy-N-ethylamphetamine (MDEA)............ 40 3,4-Methylenedioxy-N-methylcathinone (methylone)........ 40 3,4-Methylenedioxypyrovalerone (MDPV)................... 35 3-FMC; 3-Fluoro-N-methylcathinone....................... 25 3-Methylfentanyl........................................ 30 3-Methylthiofentanyl.................................... 30 4-Bromo-2,5-dimethoxyamphetamine (DOB).................. 30 4-Bromo-2,5-dimethoxyphenethylamine (2-CB).............. 25 4-Fluoroisobutyryl fentanyl............................. 30 4-FMC; Flephedrone...................................... 25 4-MEC; 4-Methyl-N-ethylcathinone........................ 25 4-Methoxyamphetamine.................................... 150 4-Methyl-2,5-dimethoxyamphetamine (DOM)................. 25 4-Methylaminorex........................................ 25 4-Methyl-N-methylcathinone (mephedrone)................. 45 4-Methyl-[alpha]-pyrrolidinopropiophenone (4-MePPP)..... 25 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]- 50 phenol................................................. 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]- 40 phenol (cannabicyclohexanol or CP-47,497 C8-homolog)... 5F-ADB; 5F-MDMB-PINACA (methyl 2-(1-(5-fluoropentyl)-1H- 30 indazole-3-carboxamido)-3,3-dimethylbutanoate)......... 5F-AMB (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3- 30 carboxamido)-3-methylbutanoate)........................ 5F-APINACA; 5F-AKB48 (N-(adamantan-1-yl)-1-(5- 30 fluoropentyl)-1H-indazole-3-carboxamide)............... 5-Fluoro-PB-22; 5F-PB-22................................ 20 5-Fluoro-UR144, XLR11 ([1-(5-fluoro-pentyl)-1Hindol-3- 25 yl](2,2,3,3-tetramethylcyclopropyl)methanone........... 5-Methoxy-3,4-methylenedioxyamphetamine................. 25 5-Methoxy-N,N-diisopropyltryptamine..................... 25 5-Methoxy-N,N-dimethyltryptamine........................ 25 [[Page 51875]] AB-CHMINACA............................................. 30 AB-FUBINACA............................................. 50 AB-PINACA............................................... 30 ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- 30 (4-fluorobenzyl)-1H-indazole-3-carboxamide)............ Acetyl Fentanyl......................................... 100 Acetyl-alpha-methylfentanyl............................. 30 Acetyldihydrocodeine.................................... 30 Acetylmethadol.......................................... 2 Acryl Fentanyl.......................................... 25 ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- 50 pentyl-1H-indazole-3-carboxamide)...................... AH-7921................................................. 30 Allylprodine............................................ 2 Alphacetylmethadol...................................... 2 alpha-Ethyltryptamine................................... 25 Alphameprodine.......................................... 2 Alphamethadol........................................... 2 alpha-Methylfentanyl.................................... 30 alpha-Methylthiofentanyl................................ 30 alpha-Methyltryptamine (AMT)............................ 25 alpha-Pyrrolidinobutiophenone ([alpha]-PBP)............. 25 alpha-Pyrrolidinopentiophenone ([alpha]-PVP)............ 25 Aminorex................................................ 25 APINCA, AKB48 (N-(1-adamantyl)-1-pentyl-1H-indazole-3- 25 carboxamide)........................................... Benzylmorphine.......................................... 30 Betacetylmethadol....................................... 2 beta-Hydroxy-3-methylfentanyl........................... 30 beta-Hydroxyfentanyl.................................... 30 beta-Hydroxythiofentanyl................................ 30 Betameprodine........................................... 2 Betamethadol............................................ 4 Betaprodine............................................. 2 Bufotenine.............................................. 3 Butylone................................................ 25 Butyryl fentanyl........................................ 30 Cathinone............................................... 24 Codeine methylbromide................................... 30 Codeine-N-oxide......................................... 192 Desomorphine............................................ 25 Diethyltryptamine....................................... 25 Difenoxin............................................... 8,225 Dihydromorphine......................................... 1,000,160 Dimethyltryptamine...................................... 35 Dipipanone.............................................. 5 Etorphine............................................... 30 Fenethylline............................................ 30 Furanyl fentanyl........................................ 30 gamma-Hydroxybutyric acid............................... 37,130,000 Heroin.................................................. 45 Hydromorphinol.......................................... 40 Hydroxypethidine........................................ 2 Ibogaine................................................ 30 JWH-018 and AM678 (1-Pentyl-3-(1-naphthoyl)indole)...... 35 JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)................. 45 JWH-073 (1-Butyl-3-(1-naphthoyl)indole)................. 45 JWH-081 (1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole)..... 30 JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole)....... 30 JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- 35 naphthoyl)indole)...................................... JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole)....... 30 JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole)...... 30 JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole)....... 30 Lysergic acid diethylamide (LSD)........................ 40 MAB-CHMINACA; ADB-CHMINACA (N-(1-amino-3,3-dimethyl-1- 30 oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- carboxamide)........................................... MDMB-CHMICA; MMB-CHMINACA(methyl 2-(1-(cyclohexylmethyl)- 30 1H-indole-3-carboxamido)-3,3-dimethylbutanoate)........ MDMB-FUBINACA (methyl 2-(1-(4-fluorobenzyl)-1H-indazole- 30 3-carboxamido)-3,3-dimethylbutanoate).................. Marihuana............................................... 443,680 Mecloqualone............................................ 30 Mescaline............................................... 25 Methaqualone............................................ 60 Methcathinone........................................... 25 Methyldesorphine........................................ 5 [[Page 51876]] Methyldihydromorphine................................... 2 Morphine methylbromide.................................. 5 Morphine methylsulfonate................................ 5 Morphine-N-oxide........................................ 150 N,N-Dimethylamphetamine................................. 25 Naphyrone............................................... 25 N-Ethyl-1-phenylcyclohexylamine......................... 5 N-Ethylamphetamine...................................... 24 N-Hydroxy-3,4-methylenedioxyamphetamine................. 24 Noracymethadol.......................................... 2 Norlevorphanol.......................................... 55 Normethadone............................................ 2 Normorphine............................................. 40 Para-fluorofentanyl..................................... 25 Parahexyl............................................... 5 PB-22; QUPIC............................................ 20 Pentedrone.............................................. 25 Pentylone............................................... 25 Phenomorphan............................................ 2 Pholcodine.............................................. 5 Psilocybin.............................................. 30 Psilocyn................................................ 50 SR-18 and RCS-8 (1-Cyclohexylethyl-3-(2- 45 methoxyphenylacetyl)indole)............................ SR-19 and RCS-4 (1-Pentyl-3-[(4-methoxy)-benzoyl]indole) 30 Tetrahydrocannabinols................................... 384,460 Thiofentanyl............................................ 25 THJ-2201 ( [1-(5-fluoropentyl)-1H-indazol-3- 30 yl](naphthalen-1-yl)methanone)......................... Tilidine................................................ 25 Trimeperidine........................................... 2 UR-144 (1-pentyl-1H-indol-3-yl)(2,2,3,3- 25 tetramethylcyclopropyl)methanone....................... U-47700................................................. 30 ------------------------------------------------------------------------ Schedule II ------------------------------------------------------------------------ 1-Phenylcyclohexylamine................................. 4 1-Piperidinocyclohexanecarbonitrile..................... 4 4-Anilino-N-phenethyl-4-piperidine (ANPP)............... 1,342,320 Alfentanil.............................................. 6,200 Alphaprodine............................................ 2 Amobarbital............................................. 20,100 Amphetamine (for conversion)............................ 11,280,000 Amphetamine (for sale).................................. 39,856,000 Carfentanil............................................. 20 Cocaine................................................. 92,120 Codeine (for conversion)................................ 15,040,000 Codeine (for sale)...................................... 40,015,800 Dextropropoxyphene...................................... 35 Dihydrocodeine.......................................... 264,140 Dihydroetorphine........................................ 2 Diphenoxylate (for conversion).......................... 14,100 Diphenoxylate (for sale)................................ 770,800 Ecgonine................................................ 88,134 Ethylmorphine........................................... 30 Etorphine hydrochloride................................. 32 Fentanyl................................................ 1,342,320 Glutethimide............................................ 2 Hydrocodone (for conversion)............................ 114,680 Hydrocodone (for sale).................................. 50,348,280 Hydromorphone........................................... 4,547,720 Isomethadone............................................ 30 Levo-alphacetylmethadol (LAAM).......................... 5 Levomethorphan.......................................... 30 Levorphanol............................................. 12,126 Lisdexamfetamine........................................ 17,869,000 Meperidine.............................................. 2,717,540 Meperidine Intermediate-A............................... 5 Meperidine Intermediate-B............................... 30 Meperidine Intermediate-C............................... 5 Metazocine.............................................. 15 Methadone (for sale).................................... 22,278,000 Methadone Intermediate.................................. 24,064,000 [[Page 51877]] Methamphetamine......................................... 1,446,754 ------------------------------------------------------------------------ [846,000 grams of levo-desoxyephedrine for use in a non-controlled, non- prescription product; 564,000 grams for methamphetamine mostly for conversion to a schedule III product; and 36,754 grams for methamphetamine (for sale)] ------------------------------------------------------------------------ Methylphenidate......................................... 64,600,000 Morphine (for conversion)............................... 4,089,000 Morphine (for sale)..................................... 33,958,440 Nabilone................................................ 31,000 Noroxymorphone (for conversion)......................... 14,044,540 Noroxymorphone (for sale)............................... 376,000 Opium (powder).......................................... 84,600 Opium (tincture)........................................ 564,000 Oripavine............................................... 24,534,000 Oxycodone (for conversion).............................. 2,453,400 Oxycodone (for sale).................................... 95,692,000 Oxymorphone (for conversion)............................ 20,962,000 Oxymorphone (for sale).................................. 3,395,280 Pentobarbital........................................... 25,850,000 Phenazocine............................................. 5 Phencyclidine........................................... 35 Phenmetrazine........................................... 25 Phenylacetone........................................... 40 Racemethorphan.......................................... 5 Racemorphan............................................. 5 Remifentanil............................................ 2,820 Secobarbital............................................ 161,682 Sufentanil.............................................. 1,880 Tapentadol.............................................. 18,388,280 Thebaine................................................ 94,000,000 ------------------------------------------------------------------------ List I Chemicals ------------------------------------------------------------------------ Ephedrine (for conversion).............................. 47,000 Ephedrine (for sale).................................... 4,136,000 Phenylpropanolamine (for conversion).................... 14,100,000 Phenylpropanolamine (for sale).......................... 7,990,000 Pseudoephedrine (for conversion)........................ 40 Pseudoephedrine (for sale).............................. 180,000,000 ------------------------------------------------------------------------ The Administrator also establishes aggregate production quotas for all other schedule I and II controlled substances included in 21 CFR 1308.11 and 1308.12 at zero. In accordance with 21 CFR 1303.13 and 21 CFR 1315.13, upon consideration of the relevant factors, the Administrator may adjust the 2018 aggregate production quotas and assessment of annual needs as needed. Dated: November 1, 2017. Robert W. Patterson, Acting Administrator. [FR Doc. 2017-24306 Filed 11-7-17; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices 51873
Issued: November 3, 2017. establishment and maintenance of at outsourcing facilities when
Lisa R. Barton, reserve stocks. These quotas include determining the Aggregate Production
Secretary to the Commission. imports of ephedrine, pseudoephedrine, Quotas. The DEA notes that it is the
[FR Doc. 2017–24323 Filed 11–7–17; 8:45 am] and phenylpropanolamine, but do not responsibility of all DEA-registered
BILLING CODE 7020–02–P
include imports of controlled dosage form manufacturers to submit
substances for use in industrial quota applications by April 1, in order
processes. for their individual business practices to
On August 7, 2017, a notice titled be considered when the DEA proposes
DEPARTMENT OF JUSTICE
‘‘Proposed Aggregate Production Quotas the Aggregate Production Quota for the
Drug Enforcement Administration for Schedule I and II Controlled following year. 21 CFR 1303.12(b).
Substances and Assessment of Annual These quota applications and comments
[Docket No. DEA–471F] Needs for the List I Chemicals with discrete data regarding the
Ephedrine, Pseudoephedrine, and quantities of the basic classes of
Established Aggregate Production Phenylpropanolamine for 2018’’ was schedule I or II controlled substances
Quotas for Schedule I and II Controlled published in the Federal Register. 82 FR received during the comment period for
Substances and Assessment of 36830. This notice proposed the 2018 the proposed Aggregate Production
Annual Needs for the List I Chemicals aggregate production quotas for each Quotas are taken into consideration
Ephedrine, Pseudoephedrine, and basic class of controlled substance listed before establishing the values presented
Phenylpropanolamine for 2018 in schedules I and II and the 2018 in this Final Order. This DEA-registered
AGENCY: Drug Enforcement assessment of annual needs for the list manufacturer provided no quantitative
Administration, Department of Justice. I chemicals ephedrine, data supporting the position that the
pseudoephedrine, and proposed quota for 2018 will adversely
ACTION: Final order.
phenylpropanolamine. All interested impact outsourcing facilities for DEA to
SUMMARY: This final order establishes persons were invited to comment on or consider. The DEA also received one
the initial 2018 aggregate production object to the proposed aggregate hundred five comments that expressed
quotas for controlled substances in production quotas and the proposed concern that DEA’s proposed reduction
schedules I and II of the Controlled assessment of annual needs on or before of opioids by twenty percent would
Substances Act and the assessment of September 6, 2017. adversely impact the availability of pain
annual needs for the list I chemicals Comments Received relieving prescription drugs for people
ephedrine, pseudoephedrine, and with chronic pain. These comments
phenylpropanolamine. Within the public comment period, were general in nature, and raised issues
the DEA received seventeen comments of specific medical illnesses and
APPLICABLE DATE: Applicable November from three DEA-registered
8, 2017. medical treatment, and therefore are
manufacturers regarding sixteen outside of the scope of this Final Order
FOR FURTHER INFORMATION CONTACT: different schedule I and II controlled for 2018. As a result, these one hundred
Michael J. Lewis, Diversion Control substances and one comment from a and six comments did not provide new
Division, Drug Enforcement DEA-registered manufacturer regarding discrete data for consideration, and do
Administration, 8701 Morrissette Drive, the proposed assessment of annual not impact the original analysis
Springfield, VA 22152, Telephone: (202) needs for the list I chemical involved in establishing the 2018
598–6812. phenylpropanolamine (for conversion). aggregate production quotas.
SUPPLEMENTARY INFORMATION: Commenters stated the proposed
aggregate production quotas for 4- Determination of 2018 Aggregate
Legal Authority anilino-n-phenethyl-4-piperadine Production Quotas and Assessment of
Section 306 of the Controlled (ANPP), amphetamine (for conversion), Annual Needs
Substances Act (CSA) (21 U.S.C. 826) codeine (for sale), diphenoxylate, In determining the 2018 aggregate
requires the Attorney General to fentanyl, gamma hydroxybutyric acid, production quotas and assessment of
establish aggregate production quotas hydrocodone (for sale), annual needs, the DEA has taken into
for each basic class of controlled lisdexamfetamine, methadone, consideration the above comments
substance listed in schedules I and II methadone-intermediate, along with the factors set forth in 21
and for the list I chemicals ephedrine, methylphenidate, morphine (for CFR 1303.11 and 21 CFR 1315.11, in
pseudoephedrine, and conversion), morphine (for sale), accordance with 21 U.S.C. 826(a), and
phenylpropanolamine. The Attorney oxycodone (for sale), oxymorphone (for other relevant factors, including the
General has delegated this function to sale), sufentanil, as well as the proposed 2017 manufacturing quotas, current
the Administrator of the DEA pursuant assessment of annual needs for 2017 sales and inventories, anticipated
to 28 CFR 0.100. phenylpropanolamine (for conversion), 2018 export requirements, industrial
were insufficient to provide for the use, additional applications for 2018
Background quotas, as well as information on
estimated medical, scientific, research,
The 2018 aggregate production quotas and industrial needs of the United research and product development
and assessment of annual needs States, export requirements, and the requirements. Based on all of the above,
represent those quantities of schedule I establishment and maintenance of the Administrator is adjusting the 2018
and II controlled substances and the list reserve stocks. These comments were aggregate production quotas for 2-(4-
I chemicals ephedrine, considered in setting the final 2018 bromo-2,5-dimethoxyphenyl)-n-(2-
ethrower on DSK3G9T082PROD with NOTICES
pseudoephedrine, and Aggregate Production Quotas as methoxybenzyl) ethanamine, 3,4,5-
phenylpropanolamine that may be discussed below. trimethoxy amphetamine, 4-bromo-2,5-
manufactured in the United States in In addition to these seventeen dimethoxy-amphetamine, acryl
2018 to provide for the estimated comments, the DEA received one fentanyl, alfentanil, amobarbital,
medical, scientific, research, industrial comment from a DEA-registered methylphenidate, and nabilone, are
needs of the United States, lawful manufacturer seeking clarification on warranted. Adjustment to the proposed
export requirements, and the whether DEA considers manufacturing assessment of annual needs for
VerDate Sep<11>2014 17:26 Nov 07, 2017 Jkt 244001 PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 E:\FR\FM\08NON1.SGM 08NON1](https://thefederalregister.org/doc/82_FR_52088/page/1.svg)
![51874 Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices
pseudoephedrine (for sale) was also phenylpropanolamine (for conversion), In accordance with 21 U.S.C. 826, 21
determined to be warranted. This final the DEA has determined the proposed CFR 1303.11, and 21 CFR 1315.11, the
order reflects those adjustments. aggregate production quotas and Administrator hereby establishes the
Regarding 4-anilino-n-phenethyl-4- assessment of annual needs are 2018 aggregate production quotas for the
piperadine (ANPP), amphetamine (for sufficient to provide for the 2018 following schedule I and II controlled
conversion), codeine (for sale), estimated medical, scientific, research, substances and the 2018 assessment of
diphenoxylate, fentanyl, gamma industrial needs of the United States, annual needs for the list I chemicals
hydroxybutyric acid, hydrocodone (for export requirements, and the ephedrine, pseudoephedrine, and
sale), lisdexamfetamine, methadone, establishment and maintenance of phenylpropanolamine, expressed in
methadone-intermediate, morphine (for reserve stocks. This final order
grams of anhydrous acid or base, as
conversion), morphine (for sale), establishes these aggregate production
follows:
oxycodone (for sale), oxymorphone (for quotas and assessment of annual needs
sale), sufentanil, and at the same amounts as proposed.
2018
Established
Basic class quotas
(g)
Temporarily Scheduled Substances
Acryl fentanyl ....................................................................................................................................................................................... 25
Schedule I
1-(1-Phenylcyclohexyl)pyrrolidine ........................................................................................................................................................ 10
1-(5-Fluoropentyl)-3-(1-naphthoyl)indole (AM2201) ............................................................................................................................ 30
1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole (AM694) ........................................................................................................................... 30
1-[1-(2-Thienyl)cyclohexyl]piperidine ................................................................................................................................................... 15
1-Benzylpiperazine .............................................................................................................................................................................. 25
1-Methyl-4-phenyl-4-propionoxypiperidine ........................................................................................................................................... 2
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) ........................................................................................................................... 30
2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) ........................................................................................................................ 30
2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) .......................................................................................................................... 30
2-(2,5-Dimethoxy-4-n-propylphenyl)ethanamine (2C-P) ...................................................................................................................... 30
2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) ....................................................................................................................................... 30
2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36) ........................ 30
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) ........................................................................................................................ 30
2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82) ........................ 25
2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) .............................................................................................................................. 30
2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5) .................................. 30
2,5-Dimethoxy-4-ethylamphetamine (DOET) ...................................................................................................................................... 25
2,5-Dimethoxy-4-n-propylthiophenethylamine ..................................................................................................................................... 25
2,5-Dimethoxyamphetamine ................................................................................................................................................................ 25
2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) ................................................................................................................ 30
2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) .......................................................................................................... 30
3,4,5-Trimethoxyamphetamine ............................................................................................................................................................ 30
3,4-Methylenedioxyamphetamine (MDA) ............................................................................................................................................ 55
3,4-Methylenedioxymethamphetamine (MDMA) ................................................................................................................................. 50
3,4-Methylenedioxy-N-ethylamphetamine (MDEA) ............................................................................................................................. 40
3,4-Methylenedioxy-N-methylcathinone (methylone) .......................................................................................................................... 40
3,4-Methylenedioxypyrovalerone (MDPV) ........................................................................................................................................... 35
3-FMC; 3-Fluoro-N-methylcathinone ................................................................................................................................................... 25
3-Methylfentanyl ................................................................................................................................................................................... 30
3-Methylthiofentanyl ............................................................................................................................................................................. 30
4-Bromo-2,5-dimethoxyamphetamine (DOB) ...................................................................................................................................... 30
4-Bromo-2,5-dimethoxyphenethylamine (2-CB) .................................................................................................................................. 25
4-Fluoroisobutyryl fentanyl ................................................................................................................................................................... 30
4-FMC; Flephedrone ............................................................................................................................................................................ 25
4-MEC; 4-Methyl-N-ethylcathinone ...................................................................................................................................................... 25
4-Methoxyamphetamine ...................................................................................................................................................................... 150
4-Methyl-2,5-dimethoxyamphetamine (DOM) ...................................................................................................................................... 25
4-Methylaminorex ................................................................................................................................................................................ 25
4-Methyl-N-methylcathinone (mephedrone) ........................................................................................................................................ 45
4-Methyl-a-pyrrolidinopropiophenone (4-MePPP) ............................................................................................................................... 25
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol ......................................................................................................... 50
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog) ........................... 40
ethrower on DSK3G9T082PROD with NOTICES
5F-ADB; 5F-MDMB-PINACA (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ............................ 30
5F-AMB (methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ................................................................... 30
5F-APINACA; 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ........................................................ 30
5-Fluoro-PB-22; 5F-PB-22 ................................................................................................................................................................... 20
5-Fluoro-UR144, XLR11 ([1-(5-fluoro-pentyl)-1Hindol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ............................................ 25
5-Methoxy-3,4-methylenedioxyamphetamine ...................................................................................................................................... 25
5-Methoxy-N,N-diisopropyltryptamine .................................................................................................................................................. 25
5-Methoxy-N,N-dimethyltryptamine ..................................................................................................................................................... 25
VerDate Sep<11>2014 17:26 Nov 07, 2017 Jkt 244001 PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 E:\FR\FM\08NON1.SGM 08NON1](https://thefederalregister.org/doc/82_FR_52088/page/2.svg)
![Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices 51875
2018
Established
Basic class quotas
(g)
AB-CHMINACA .................................................................................................................................................................................... 30
AB-FUBINACA ..................................................................................................................................................................................... 50
AB-PINACA .......................................................................................................................................................................................... 30
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .................................. 30
Acetyl Fentanyl .................................................................................................................................................................................... 100
Acetyl-alpha-methylfentanyl ................................................................................................................................................................. 30
Acetyldihydrocodeine ........................................................................................................................................................................... 30
Acetylmethadol .................................................................................................................................................................................... 2
Acryl Fentanyl ...................................................................................................................................................................................... 25
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ...................................................... 50
AH-7921 ............................................................................................................................................................................................... 30
Allylprodine .......................................................................................................................................................................................... 2
Alphacetylmethadol .............................................................................................................................................................................. 2
alpha-Ethyltryptamine .......................................................................................................................................................................... 25
Alphameprodine ................................................................................................................................................................................... 2
Alphamethadol ..................................................................................................................................................................................... 2
alpha-Methylfentanyl ............................................................................................................................................................................ 30
alpha-Methylthiofentanyl ...................................................................................................................................................................... 30
alpha-Methyltryptamine (AMT) ............................................................................................................................................................ 25
alpha-Pyrrolidinobutiophenone (a-PBP) .............................................................................................................................................. 25
alpha-Pyrrolidinopentiophenone (a-PVP) ............................................................................................................................................ 25
Aminorex .............................................................................................................................................................................................. 25
APINCA, AKB48 (N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ......................................................................................... 25
Benzylmorphine ................................................................................................................................................................................... 30
Betacetylmethadol ............................................................................................................................................................................... 2
beta-Hydroxy-3-methylfentanyl ............................................................................................................................................................ 30
beta-Hydroxyfentanyl ........................................................................................................................................................................... 30
beta-Hydroxythiofentanyl ..................................................................................................................................................................... 30
Betameprodine ..................................................................................................................................................................................... 2
Betamethadol ....................................................................................................................................................................................... 4
Betaprodine .......................................................................................................................................................................................... 2
Bufotenine ............................................................................................................................................................................................ 3
Butylone ............................................................................................................................................................................................... 25
Butyryl fentanyl .................................................................................................................................................................................... 30
Cathinone ............................................................................................................................................................................................. 24
Codeine methylbromide ....................................................................................................................................................................... 30
Codeine-N-oxide .................................................................................................................................................................................. 192
Desomorphine ...................................................................................................................................................................................... 25
Diethyltryptamine ................................................................................................................................................................................. 25
Difenoxin .............................................................................................................................................................................................. 8,225
Dihydromorphine .................................................................................................................................................................................. 1,000,160
Dimethyltryptamine .............................................................................................................................................................................. 35
Dipipanone ........................................................................................................................................................................................... 5
Etorphine .............................................................................................................................................................................................. 30
Fenethylline .......................................................................................................................................................................................... 30
Furanyl fentanyl ................................................................................................................................................................................... 30
gamma-Hydroxybutyric acid ................................................................................................................................................................ 37,130,000
Heroin .................................................................................................................................................................................................. 45
Hydromorphinol .................................................................................................................................................................................... 40
Hydroxypethidine ................................................................................................................................................................................. 2
Ibogaine ............................................................................................................................................................................................... 30
JWH-018 and AM678 (1-Pentyl-3-(1-naphthoyl)indole) ...................................................................................................................... 35
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ........................................................................................................................................... 45
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ............................................................................................................................................ 45
JWH-081 (1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole) ....................................................................................................................... 30
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) ........................................................................................................................... 30
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ............................................................................................................... 35
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) ............................................................................................................................ 30
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) ........................................................................................................................ 30
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole) ............................................................................................................................ 30
Lysergic acid diethylamide (LSD) ........................................................................................................................................................ 40
MAB-CHMINACA; ADB-CHMINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-
carboxamide) .................................................................................................................................................................................... 30
ethrower on DSK3G9T082PROD with NOTICES
MDMB-CHMICA; MMB-CHMINACA(methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ................. 30
MDMB-FUBINACA (methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ........................................... 30
Marihuana ............................................................................................................................................................................................ 443,680
Mecloqualone ....................................................................................................................................................................................... 30
Mescaline ............................................................................................................................................................................................. 25
Methaqualone ...................................................................................................................................................................................... 60
Methcathinone ..................................................................................................................................................................................... 25
Methyldesorphine ................................................................................................................................................................................. 5
VerDate Sep<11>2014 17:26 Nov 07, 2017 Jkt 244001 PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 E:\FR\FM\08NON1.SGM 08NON1](https://thefederalregister.org/doc/82_FR_52088/page/3.svg)
![51876 Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices
2018
Established
Basic class quotas
(g)
Methyldihydromorphine ........................................................................................................................................................................ 2
Morphine methylbromide ..................................................................................................................................................................... 5
Morphine methylsulfonate .................................................................................................................................................................... 5
Morphine-N-oxide ................................................................................................................................................................................ 150
N,N-Dimethylamphetamine .................................................................................................................................................................. 25
Naphyrone ........................................................................................................................................................................................... 25
N-Ethyl-1-phenylcyclohexylamine ........................................................................................................................................................ 5
N-Ethylamphetamine ........................................................................................................................................................................... 24
N-Hydroxy-3,4-methylenedioxyamphetamine ...................................................................................................................................... 24
Noracymethadol ................................................................................................................................................................................... 2
Norlevorphanol ..................................................................................................................................................................................... 55
Normethadone ..................................................................................................................................................................................... 2
Normorphine ........................................................................................................................................................................................ 40
Para-fluorofentanyl ............................................................................................................................................................................... 25
Parahexyl ............................................................................................................................................................................................. 5
PB-22; QUPIC ..................................................................................................................................................................................... 20
Pentedrone .......................................................................................................................................................................................... 25
Pentylone ............................................................................................................................................................................................. 25
Phenomorphan .................................................................................................................................................................................... 2
Pholcodine ........................................................................................................................................................................................... 5
Psilocybin ............................................................................................................................................................................................. 30
Psilocyn ................................................................................................................................................................................................ 50
SR-18 and RCS-8 (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole) ........................................................................................... 45
SR-19 and RCS-4 (1-Pentyl-3-[(4-methoxy)-benzoyl]indole) .............................................................................................................. 30
Tetrahydrocannabinols ........................................................................................................................................................................ 384,460
Thiofentanyl ......................................................................................................................................................................................... 25
THJ-2201 ( [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) .................................................................................... 30
Tilidine .................................................................................................................................................................................................. 25
Trimeperidine ....................................................................................................................................................................................... 2
UR-144 (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ...................................................................................... 25
U-47700 ............................................................................................................................................................................................... 30
Schedule II
1-Phenylcyclohexylamine .................................................................................................................................................................... 4
1-Piperidinocyclohexanecarbonitrile .................................................................................................................................................... 4
4-Anilino-N-phenethyl-4-piperidine (ANPP) ......................................................................................................................................... 1,342,320
Alfentanil .............................................................................................................................................................................................. 6,200
Alphaprodine ........................................................................................................................................................................................ 2
Amobarbital .......................................................................................................................................................................................... 20,100
Amphetamine (for conversion) ............................................................................................................................................................ 11,280,000
Amphetamine (for sale) ....................................................................................................................................................................... 39,856,000
Carfentanil ............................................................................................................................................................................................ 20
Cocaine ................................................................................................................................................................................................ 92,120
Codeine (for conversion) ..................................................................................................................................................................... 15,040,000
Codeine (for sale) ................................................................................................................................................................................ 40,015,800
Dextropropoxyphene ............................................................................................................................................................................ 35
Dihydrocodeine .................................................................................................................................................................................... 264,140
Dihydroetorphine .................................................................................................................................................................................. 2
Diphenoxylate (for conversion) ............................................................................................................................................................ 14,100
Diphenoxylate (for sale) ....................................................................................................................................................................... 770,800
Ecgonine .............................................................................................................................................................................................. 88,134
Ethylmorphine ...................................................................................................................................................................................... 30
Etorphine hydrochloride ....................................................................................................................................................................... 32
Fentanyl ............................................................................................................................................................................................... 1,342,320
Glutethimide ......................................................................................................................................................................................... 2
Hydrocodone (for conversion) ............................................................................................................................................................. 114,680
Hydrocodone (for sale) ........................................................................................................................................................................ 50,348,280
Hydromorphone ................................................................................................................................................................................... 4,547,720
Isomethadone ...................................................................................................................................................................................... 30
Levo-alphacetylmethadol (LAAM) ........................................................................................................................................................ 5
Levomethorphan .................................................................................................................................................................................. 30
Levorphanol ......................................................................................................................................................................................... 12,126
ethrower on DSK3G9T082PROD with NOTICES
Lisdexamfetamine ................................................................................................................................................................................ 17,869,000
Meperidine ........................................................................................................................................................................................... 2,717,540
Meperidine Intermediate-A .................................................................................................................................................................. 5
Meperidine Intermediate-B .................................................................................................................................................................. 30
Meperidine Intermediate-C .................................................................................................................................................................. 5
Metazocine ........................................................................................................................................................................................... 15
Methadone (for sale) ........................................................................................................................................................................... 22,278,000
Methadone Intermediate ...................................................................................................................................................................... 24,064,000
VerDate Sep<11>2014 17:26 Nov 07, 2017 Jkt 244001 PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 E:\FR\FM\08NON1.SGM 08NON1](https://thefederalregister.org/doc/82_FR_52088/page/4.svg)
![Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices 51877
2018
Established
Basic class quotas
(g)
Methamphetamine ............................................................................................................................................................................... 1,446,754
[846,000 grams of levo-desoxyephedrine for use in a non-controlled, non-prescription product; 564,000 grams for methamphetamine mostly for
conversion to a schedule III product; and 36,754 grams for methamphetamine (for sale)]
Methylphenidate ................................................................................................................................................................................... 64,600,000
Morphine (for conversion) .................................................................................................................................................................... 4,089,000
Morphine (for sale) .............................................................................................................................................................................. 33,958,440
Nabilone ............................................................................................................................................................................................... 31,000
Noroxymorphone (for conversion) ....................................................................................................................................................... 14,044,540
Noroxymorphone (for sale) .................................................................................................................................................................. 376,000
Opium (powder) ................................................................................................................................................................................... 84,600
Opium (tincture) ................................................................................................................................................................................... 564,000
Oripavine .............................................................................................................................................................................................. 24,534,000
Oxycodone (for conversion) ................................................................................................................................................................ 2,453,400
Oxycodone (for sale) ........................................................................................................................................................................... 95,692,000
Oxymorphone (for conversion) ............................................................................................................................................................ 20,962,000
Oxymorphone (for sale) ....................................................................................................................................................................... 3,395,280
Pentobarbital ........................................................................................................................................................................................ 25,850,000
Phenazocine ........................................................................................................................................................................................ 5
Phencyclidine ....................................................................................................................................................................................... 35
Phenmetrazine ..................................................................................................................................................................................... 25
Phenylacetone ..................................................................................................................................................................................... 40
Racemethorphan ................................................................................................................................................................................. 5
Racemorphan ...................................................................................................................................................................................... 5
Remifentanil ......................................................................................................................................................................................... 2,820
Secobarbital ......................................................................................................................................................................................... 161,682
Sufentanil ............................................................................................................................................................................................. 1,880
Tapentadol ........................................................................................................................................................................................... 18,388,280
Thebaine .............................................................................................................................................................................................. 94,000,000
List I Chemicals
Ephedrine (for conversion) .................................................................................................................................................................. 47,000
Ephedrine (for sale) ............................................................................................................................................................................. 4,136,000
Phenylpropanolamine (for conversion) ................................................................................................................................................ 14,100,000
Phenylpropanolamine (for sale) ........................................................................................................................................................... 7,990,000
Pseudoephedrine (for conversion) ...................................................................................................................................................... 40
Pseudoephedrine (for sale) ................................................................................................................................................................. 180,000,000
The Administrator also establishes DEPARTMENT OF JUSTICE 600 E Street NW., Suite 6002,
aggregate production quotas for all other Washington, DC 20579. Telephone:
schedule I and II controlled substances Foreign Claims Settlement (202) 616–6975.
included in 21 CFR 1308.11 and Commission
Brian M. Simkin,
1308.12 at zero. In accordance with 21 [F.C.S.C. Meeting and Hearing Notice No. Chief Counsel.
CFR 1303.13 and 21 CFR 1315.13, upon 10–17]
[FR Doc. 2017–24361 Filed 11–6–17; 8:45 am]
consideration of the relevant factors, the
Administrator may adjust the 2018 Sunshine Act Meeting BILLING CODE 4410–BA–P
aggregate production quotas and The Foreign Claims Settlement
assessment of annual needs as needed. Commission, pursuant to its regulations DEPARTMENT OF JUSTICE
Dated: November 1, 2017. (45 CFR part 503.25) and the
Government in the Sunshine Act (5 Notice of Lodging of Proposed
Robert W. Patterson,
U.S.C. 552b), hereby gives notice in Consent Decree Under the Clean Air
Acting Administrator. regard to the scheduling of open Act
[FR Doc. 2017–24306 Filed 11–7–17; 8:45 am] meetings as follows:
BILLING CODE 4410–09–P THURSDAY, NOVEMBER 16, 2017: 10:00 On October 31, 2017, the Department
a.m.—Issuance of Proposed Decisions in of Justice lodged a proposed consent
claims against Iraq. decree with the United States District
STATUS: Open. Court for the District of Colorado in the
ethrower on DSK3G9T082PROD with NOTICES
All meetings are held at the Foreign lawsuit entitled United States of
Claims Settlement Commission, 600 E America and the State of Colorado v.
Street NW., Washington, DC. Requests PDC Energy, Inc., Civil Action No. 1:17–
for information, or advance notices of cv–01552–MSK–MJW.
intention to observe an open meeting, The lawsuit seeks injunctive relief
may be directed to: Patricia M. Hall, and civil penalties for violations of the
Foreign Claims Settlement Commission, Clean Air Act, the Colorado Air
VerDate Sep<11>2014 17:26 Nov 07, 2017 Jkt 244001 PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 E:\FR\FM\08NON1.SGM 08NON1](https://thefederalregister.org/doc/82_FR_52088/page/5.svg)
Document Created: 2017-11-08 01:20:39
Document Modified: 2017-11-08 01:20:39
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Final order. | |
| Dates | Applicable November 8, 2017. | |
| Contact | Michael J. Lewis, Diversion Control Division, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, VA 22152, Telephone: (202) 598-6812. | |
| FR Citation | 82 FR 51873 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR